Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Hemoglobin Electrophoresis: The Normal Breakdown of Adult Hemoglobin…

Two Onc Docs

S. Armstrong, K. Tawagi

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Sickle Cell Disease Updates: Clinical Trials, Current Therapies, and…

Marwan Shaikh

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

ASH 2024 Review: AI in Classical Hematology

Cleveland Clinic Taussig Cancer Institute

R. Patell

How to Approach Anemia

Icahn School of Medicine at Mount Sinai

C. Cromwell

Sickle Cell Disease Updates: Incidence, Barriers, Survival Rates, an…

Marwan Shaikh

ACP 2024 Insights: Sickle Cell Anemia - Diagnosis and Management of …

Insights from 2024 ACP Annual Meeting

M. Okam Achebe

Sickle Cell Disease: Epidemiology, Pathophysiology, Clinical Present…

Baystate Health

R. Steingart

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Role of Antiplatelet and Anticoagulant Therapy: Managing Vaso-Occlus…

Erica Sparkenbaugh

Management of Patients with Sickle Cell Anemia, Hospitalist Edition

Duke Health

R. Doshi

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…

Yale Cancer Center

J. Ryu

Management of Hematologic Conditions in Athletes

Scripps Health

R. Kasthuri

A Guide for Shared Decision Making in Sickle Cell Disease

UCSF School of Medicine

M. Treadwell

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

Nirmish Shah

Breakthroughs in the Care of Sickle Cell Disease

Yale Cancer Center

C. Calhoun, E. Winer